Loading...
53 Philippines Healthcare Reports
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Medtronic, Roche, NovoNordisk, Abbott, Dexcom
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Medtronics, Roche, NovoNordisk, Sanofi, Omnipod
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Astrazeneca, Astellas, Janssen, Eli Lilly, Sanofi
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Dexcom, Medtronic, Abbott, Senseonics, Ascensia
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Roche, Medtronics, Dexcom, Abbott Diabetes Care, Johnson & Johnson
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: I-Sens, Abbott Diabetes Care, Ascensia Diabetes Care, LifeScan Inc., Roche Diabetes Care
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly and Company, Ypsomed Holding
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Becton and Dickinson, Terumo Corporation, Nipro Corporation, HMD Healthcare Ltd., Cardinal Health Inc.
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Medtronic, Ypsomed, Insulet, Roche, Tandem Diabetes Care
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.
Country Covered: Philippines
Study Period: 2019-2029
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Biocon, Wockhardt, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen
Country Covered: Philippines
Study Period: 2018-2029
Major Players: Novo Nordisk A/S
Country Covered: Philippines
Study Period: 2018-2029
Major Players: Novo Nordisk A/S
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Thermo Fisher Scientific Inc., Abbott Laboratories, InBios International, Inc., NovaTec Immundiagnostica GmbH, F. Hoffmann-La Roche Ltd.
Country Covered: Philippines
Study Period: 2018-2029
Major Players: Abbott, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Arkray, Inc., Beckman Coulter, Inc.
Country Covered: Philippines
Study Period: 2021 - 2029
Major Players: Medtronic Plc, Dexcom, Inc., Abbott Laboratories, Senseonics Holdings, Inc., Roche
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Novo Nordisk A/S, Medtronic, Dexcom Inc., Abbott Diabetes Care, Roche Diabetes Care
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: Roche Diabetes Care, Ascensia Diabetes Care, Abbott Diabetes Care, LifeScan Inc., Arkray Inc.
Country Covered: Philippines
Study Period: 2018 - 2029
Major Players: F. Hoffmann-La Roche AG, Abbott Diabetes Care, Ascensia Diabetes Care, LifeScan Inc., ARKRAY Inc.